GRI Bio (GRI) Share-based Compensation (2020 - 2026)
GRI Bio (GRI) reported Share-based Compensation of $33,000 for Q2 2026, down 19.5% from $41,000 a year earlier but up 6.5% from the prior quarter.
Powered by 
Analysis
GRI Bio (GRI) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, GRI Bio's Share-based Compensation came in at $596,000, up 77.9% year-over-year; for FY2025, it was $793,000, up 435.8% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 38.8% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $148,000 in FY2024 (-61.9%), $388,000 in FY2023, $25,000 in FY2022 (-96.0%) and $626,000 in FY2021 (+306.5%).
- Five-year quarterly Share-based Compensation spans a low of -$181,000 in Q2 2022 and a high of $465,000 in Q3 2025.
- Year over year, Share-based Compensation gained in four of the last seven quarters, with growth averaging 56.5%.
- The high point for year-over-year Share-based Compensation in five years was Q1 2025 (growth of 494.6%); the low point was Q1 2023 (a decline of 92.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $31,000 (Q1 2026), $67,000 (Q4 2025) and $465,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | GRI Bio | 3.79 Mn | 3.79 Mn | - | 33,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Dec 31, 2024 | 37,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 36,000.00 |
| Sep 30, 2023 | 326,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Jun 30, 2022 | -181,000.00 |
| Mar 31, 2022 | 181,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 134,000.00 |
| Jun 30, 2021 | 138,000.00 |
API Access
GRI Bio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "GRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();